JPWO2020210247A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020210247A5 JPWO2020210247A5 JP2021559971A JP2021559971A JPWO2020210247A5 JP WO2020210247 A5 JPWO2020210247 A5 JP WO2020210247A5 JP 2021559971 A JP2021559971 A JP 2021559971A JP 2021559971 A JP2021559971 A JP 2021559971A JP WO2020210247 A5 JPWO2020210247 A5 JP WO2020210247A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- chain variable
- variable region
- polypeptide sequence
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962832975P | 2019-04-12 | 2019-04-12 | |
| US62/832,975 | 2019-04-12 | ||
| US201962863330P | 2019-06-19 | 2019-06-19 | |
| US62/863,330 | 2019-06-19 | ||
| US201962931988P | 2019-11-07 | 2019-11-07 | |
| US62/931,988 | 2019-11-07 | ||
| PCT/US2020/027092 WO2020210247A1 (en) | 2019-04-12 | 2020-04-07 | Humanized anti-folate receptor 1 chimeric antigen receptors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526841A JP2022526841A (ja) | 2022-05-26 |
| JPWO2020210247A5 true JPWO2020210247A5 (https=) | 2022-06-29 |
| JP2022526841A5 JP2022526841A5 (https=) | 2022-06-29 |
Family
ID=72751784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559971A Pending JP2022526841A (ja) | 2019-04-12 | 2020-04-07 | ヒト化抗葉酸受容体１キメラ抗原受容体及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220162301A1 (https=) |
| EP (1) | EP3953392A1 (https=) |
| JP (1) | JP2022526841A (https=) |
| KR (1) | KR20210151173A (https=) |
| CN (1) | CN113728007B (https=) |
| AU (1) | AU2020272672A1 (https=) |
| BR (1) | BR112021017046A2 (https=) |
| CA (1) | CA3132204A1 (https=) |
| IL (1) | IL287156A (https=) |
| MX (1) | MX2021012488A (https=) |
| SG (1) | SG11202109051PA (https=) |
| WO (1) | WO2020210247A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021392032A1 (en) | 2020-12-03 | 2023-06-22 | Century Therapeutics, Inc. | Genetically engineered cells and uses thereof |
| US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
| AR124414A1 (es) | 2020-12-18 | 2023-03-22 | Century Therapeutics Inc | Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable |
| WO2025049981A1 (en) * | 2023-09-01 | 2025-03-06 | Institute For Environmental Health, Inc. | Variably deamidated gluten polypeptides and antibodies against same |
| WO2025087935A1 (en) * | 2023-10-26 | 2025-05-01 | Miltenyi Biotec B.V. & Co. KG | Chimeric antigen receptor specific for folate receptor 1 |
| CN120005830A (zh) * | 2023-11-06 | 2025-05-16 | 复星凯瑞(上海)生物科技有限公司 | 一种分泌cd47-pd-l1的基因修饰的免疫细胞的制备及应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| EP4012714A1 (en) * | 2010-03-23 | 2022-06-15 | Iogenetics, LLC. | Bioinformatic processes for determination of peptide binding |
| ES2548686T3 (es) * | 2010-10-07 | 2015-10-20 | Ac Immune S.A. | Anticuerpos que reconocen fosfo-Tau |
| HUE049693T2 (hu) * | 2012-08-31 | 2020-10-28 | Immunogen Inc | Diagnosztikai ASSAY-k és készletek a folát receptor 1 kimutatására |
| US9598489B2 (en) * | 2012-10-05 | 2017-03-21 | The Trustees Of The Univeristy Of Pennsylvania | Human alpha-folate receptor chimeric antigen receptor |
| GB201507368D0 (en) * | 2015-04-30 | 2015-06-17 | Ucl Business Plc | Cell |
| PT3294764T (pt) * | 2015-05-15 | 2021-02-15 | Hope City | Composições de recetores de antigénios quiméricos |
| CN114891751A (zh) * | 2016-06-20 | 2022-08-12 | 上海细胞治疗研究院 | 一种高效稳定表达激活型抗体的car-t细胞及其用途 |
| CN109536455B (zh) * | 2018-12-11 | 2020-02-21 | 武汉波睿达生物科技有限公司 | 一种car-nk细胞及其制备方法和应用 |
-
2020
- 2020-04-07 US US17/593,094 patent/US20220162301A1/en not_active Abandoned
- 2020-04-07 KR KR1020217036671A patent/KR20210151173A/ko not_active Withdrawn
- 2020-04-07 EP EP20788662.3A patent/EP3953392A1/en not_active Withdrawn
- 2020-04-07 CN CN202080026518.6A patent/CN113728007B/zh active Active
- 2020-04-07 MX MX2021012488A patent/MX2021012488A/es unknown
- 2020-04-07 CA CA3132204A patent/CA3132204A1/en active Pending
- 2020-04-07 AU AU2020272672A patent/AU2020272672A1/en not_active Abandoned
- 2020-04-07 BR BR112021017046A patent/BR112021017046A2/pt not_active Application Discontinuation
- 2020-04-07 JP JP2021559971A patent/JP2022526841A/ja active Pending
- 2020-04-07 SG SG11202109051P patent/SG11202109051PA/en unknown
- 2020-04-07 WO PCT/US2020/027092 patent/WO2020210247A1/en not_active Ceased
-
2021
- 2021-10-11 IL IL287156A patent/IL287156A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022526420A5 (https=) | ||
| JP2022526841A5 (https=) | ||
| Lu et al. | A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity | |
| CN114805575B (zh) | 人源化抗cd73抗体 | |
| US7498142B2 (en) | Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies | |
| JP2021514664A5 (https=) | ||
| JP2022527173A5 (https=) | ||
| JP2020501531A5 (https=) | ||
| IL276830B1 (en) | Anti-claudin 18.2 antibodies and their uses | |
| JP2020528750A5 (https=) | ||
| JP2017186337A5 (https=) | ||
| JP2021528047A5 (https=) | ||
| WO2012076066A1 (en) | Anti-ror1 antibodies and uses thereof | |
| JPWO2019173420A5 (https=) | ||
| RU2014101669A (ru) | Агенты, связывающие белки r-спондины (rspo), и способы их применения | |
| IL310938A (en) | Anti-CCR8 antibodies and their uses | |
| JP2011157397A5 (https=) | ||
| CN111278861A (zh) | Pd-l1抗体、其抗原结合片段及医药用途 | |
| TW200918556A (en) | Treatment of tumors using specific anti-L1 antibody | |
| JPWO2020210067A5 (https=) | ||
| JP2021508468A (ja) | メディトープ対応ｔ細胞 | |
| WO2019136405A1 (en) | Multi-specific ligand binders | |
| JPWO2020210247A5 (https=) | ||
| JPWO2019217145A5 (https=) | ||
| JPWO2020205331A5 (https=) |